The data illustrates the number of public biotech companies in the U.S. from 2012 to 2014, sorted by geographic area (metropolitan region). In New England, there were 58 public biotech companies operating in 2013.
San Francisco Bay Area | 66 | 80 | |
New England | 58 | 75 | |
San Diego | 38 | 44 | |
New York State | 29 | 34 | |
New Jersey | 22 | 25 | |
Mid-Atlantic | 19 | 20 | |
Los Angeles/Orange County | 15 | 19 | |
Southeast | 17 | 19 | |
Pacific Northwest | 12 | 16 | |
North Carolina | 11 | 13 | |
Midwest | 11 | 12 | |
Pennsylvania/Delaware Valley | 11 | 12 | |
Texas | 8 | 9 | |
Colorado | 6 | 7 | |
Utah | 4 | 4 | |
Other | 12 | 14 |